Literature DB >> 9255033

The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group.

N Terakawa1, J Kigawa, Y Taketani, H Yoshikawa, A Yajima, K Noda, H Okada, J Kato, M Yakushiji, O Tanizawa, S Fujimoto, S Nozawa, T Takahashi, K Hasumi, N Furuhashi, T Aono, A Sakamoto, M Furusato.   

Abstract

OBJECTIVE: To clarify the behavior of endometrial hyperplasia in a prospective study.
METHOD: Fifty-one patients with endometrial hyperplasia were followed up for 6 months. Samples of endometrial tissues were taken by uterine endometrial biopsy every 4 weeks during the first 3 months and at the end of follow-up.
RESULTS: In 69% (35/51) of the patients histological picture of the endometrium became normal during the observation period. The lesions persisted in 17% (6/35) of the patients with simple hyperplasia, in 25% (1/4) of those with complex hyperplasia, in 14% (1/7) of those with simple atypical hyperplasia, and in 80% (4/5) of the patients with complex atypical hyperplasia. In the remaining 3 patients with simple hyperplasia, the lesions progressed to complex atypical hyperplasia by the end of follow-up, after showing a normal endometrium.
CONCLUSION: Most cases of endometrial hyperplasia, except for complex atypical hyperplasia, disappeared spontaneously within a short period of time.

Entities:  

Mesh:

Year:  1997        PMID: 9255033     DOI: 10.1111/j.1447-0756.1997.tb00836.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  10 in total

1.  Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

2.  The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women.

Authors:  Seo Yeong Lee; Mi Kyoung Kim; Hyun Park; Bo Sung Yoon; Seok Ju Seong; Jin Hee Kang; Hye Sun Jun; Chong Taik Park
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

Review 3.  Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.

Authors:  Susan Furness; Helen Roberts; Jane Marjoribanks; Anne Lethaby
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  Histopathological pattern of endometrial biopsies in patients with abnormal uterine bleeding in a tertiary referral hospital in Jordan.

Authors:  Eman Husssein Alshdaifat; Sami Saif El-Deen Al-Horani; Majd Mahmoud Al-Sous; Sharaf Al-Horani; Fernas Emile Sahawneh; Amer Mahmoud Sindiani
Journal:  Ann Saudi Med       Date:  2022-06-02       Impact factor: 1.707

5.  Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.

Authors:  James V Lacey; Mark E Sherman; Brenda B Rush; Brigitte M Ronnett; Olga B Ioffe; Máire A Duggan; Andrew G Glass; Douglas A Richesson; Nilanjan Chatterjee; Bryan Langholz
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

6.  Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

Review 7.  Therapeutic options for management of endometrial hyperplasia.

Authors:  Vishal Chandra; Jong Joo Kim; Doris Mangiaracina Benbrook; Anila Dwivedi; Rajani Rai
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

Review 8.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

9.  Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.

Authors:  J V Lacey; O B Ioffe; B M Ronnett; B B Rush; D A Richesson; N Chatterjee; B Langholz; A G Glass; M E Sherman
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

10.  The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia.

Authors:  K Yoshinaga; H Sasano; T Furukawa; H Yamakawa; M Yuki; S Sato; A Yajima; A Horii
Journal:  Jpn J Cancer Res       Date:  1998-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.